🔬 Predictive Modeling for ADMET Properties to Mitigate Drug Failure in Later Clinical Stages
Moving Beyond Efficacy to Assess the Critical Pharmacokinetic and Safety Profile A significant reason for the high failure rate of potential therapeutic agents in human trials is not a lack of efficacy, but poor Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties. Computational simulation allows these crucial safety and pharmacokinetic hurdles to be assessed...
0 Comments 0 Shares 180 Views 0 Reviews